Neurol. praxi. 2020;21(5):344-348 | DOI: 10.36290/neu.2020.043

Evaluating a patient with neuropathic pain in a neurological outpatient practice

doc. MUDr. Eva Vlčková, Ph.D., prof. MUDr. Josef Bednařík, CSc.
Neurologická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno

Pain represents one of the most frequent clinical symptoms. According to the recent epidemiological studies, most of one third of neurological patients suffer from pain. Both the neuropathic and/or nociceptive pain may occure in neurological patients and their differentiation is highly important (among others due to their different treatment). The diagnostic process in pain patient consists from several steps. The first one is based on the data from medical history and is focused on history of relevant neurological lesion or disease and presence of pain in neuroanatomically plausile distribution, and also on the pain character and intensity and pain-worsening or relieving factors. Clinical neurological examination confirming the presence of sensory signs in the distribution of pain represents the second step. Finally, the third step is based on the confirmation of the lesion/disease of somatosensory nervous system using imaging, electrophysiological, neuropathological or genetic tests. In neuropathic pain patients, these steps allow the stratification into possible, probable, and definite diagnosis.

Keywords: pain, neuropathic pain, medical history, questionnaire, sensory examination.

Received: May 4, 2020; Revised: May 4, 2020; Accepted: May 4, 2020; Prepublished online: May 4, 2020; Published: November 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlčková E, Bednařík J. Evaluating a patient with neuropathic pain in a neurological outpatient practice. Neurol. praxi. 2020;21(5):344-348. doi: 10.36290/neu.2020.043.
Download citation

References

  1. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17(9): 1113-e88. Go to original source... Go to PubMed...
  2. Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, Rice AS, Rolke R, Treede RD, Serra J, Toelle T, Tugnoli V, Walk D, Walalce MS, Ware M, Yarnitsky D, Ziegler D. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154(9): 1807-1819. Go to original source... Go to PubMed...
  3. Bednařík J, Ambler Z, Opavský J, Keller O, Rokyta R, Mazanec R, Lejčko J, Kozák J, Suchý M, Pátá M, Kožený P. Klinický standard pro farmakoterapii neuropatické bolesti. Cesk Slov Neurol N 2012; 75/108(1): 93-101.
  4. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990; 41(2): 139-150. Go to original source... Go to PubMed...
  5. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29-36. Go to original source... Go to PubMed...
  6. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108: 248-257. Go to original source... Go to PubMed...
  7. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136: 380-387. Go to original source... Go to PubMed...
  8. Cragg JJ, Warner FM, Shupler MS, Jutzeler CR, Cashman N, Whitehurst DGT, Kramer JK. Prevalence of chronic pain among individuals with neurological conditions. Health Rep 2018; 29(3): 11-16.
  9. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113(1-2): 9-19. Go to original source... Go to PubMed...
  10. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14(2): 162-73. Go to original source... Go to PubMed...
  11. Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; 157(8): 1599-1606. Go to original source... Go to PubMed...
  12. Frank AJ, Moll JM, Hort JF. A comparison of three ways of measuring pain. Rheumatol Rehabil 1982; 21(4): 211-217. Go to original source... Go to PubMed...
  13. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-1920. Go to original source... Go to PubMed...
  14. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152(1): 14-27. Go to original source... Go to PubMed...
  15. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001; 93(2): 173-183. Go to original source... Go to PubMed...
  16. Rokyta R. Léčba bolesti v primární péči. Praha: Grada 2017.
  17. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006a; 123: 231-243. Go to original source... Go to PubMed...
  18. Šrotová I, Vlčková E, Straková J, Kincová S, Ryba L, Dušek L Bednařík J. Validace české verze Neuropathic Pain Symptom Inventory (NPSIcz). Cesk Slov Neurol N 2015b; 78/111: 45-56.
  19. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006; 7(4): 281-289. Go to original source... Go to PubMed...
  20. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70(18): 1630-1635. Go to original source... Go to PubMed...
  21. Vlčková E, Šrotová I. Vyšetření senzitivity (minimonografie). Cesk Slov Neurol N 2014; 77/110(4): 402-418.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.